CAMPIOTTI, LEONARDO
 Distribuzione geografica
Continente #
NA - Nord America 5.944
EU - Europa 3.360
AS - Asia 1.703
SA - Sud America 313
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 11.353
Nazione #
US - Stati Uniti d'America 5.873
IT - Italia 1.789
SG - Singapore 651
UA - Ucraina 401
CN - Cina 301
SE - Svezia 293
BR - Brasile 263
VN - Vietnam 263
DE - Germania 252
HK - Hong Kong 231
IE - Irlanda 139
TR - Turchia 138
FR - Francia 100
GB - Regno Unito 98
RU - Federazione Russa 88
FI - Finlandia 62
MX - Messico 37
IN - India 34
NL - Olanda 33
CA - Canada 29
AR - Argentina 22
AT - Austria 19
PL - Polonia 19
BE - Belgio 17
JP - Giappone 17
BD - Bangladesh 15
ES - Italia 15
ZA - Sudafrica 14
EC - Ecuador 8
LT - Lituania 7
IQ - Iraq 6
PE - Perù 6
ID - Indonesia 5
PT - Portogallo 5
SA - Arabia Saudita 5
VE - Venezuela 5
CO - Colombia 4
EU - Europa 4
MD - Moldavia 4
PH - Filippine 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CH - Svizzera 3
CL - Cile 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
MK - Macedonia 3
UZ - Uzbekistan 3
AM - Armenia 2
CR - Costa Rica 2
DZ - Algeria 2
IL - Israele 2
JM - Giamaica 2
LK - Sri Lanka 2
MY - Malesia 2
RO - Romania 2
RS - Serbia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
LB - Libano 1
LU - Lussemburgo 1
ME - Montenegro 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
NR - Nauru 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.353
Città #
Milan 1.059
Fairfield 816
Ashburn 502
Chandler 439
Woodbridge 414
Singapore 349
Houston 340
Seattle 327
Jacksonville 319
Wilmington 319
Cambridge 260
Hong Kong 230
Ann Arbor 210
Dallas 200
Dearborn 180
Nyköping 178
Princeton 156
Beijing 141
Dublin 139
Como 109
Boardman 101
New York 86
Dong Ket 85
Rome 80
Izmir 59
San Diego 59
Munich 50
Chicago 46
The Dalles 46
Kocaeli 44
Los Angeles 41
Redmond 37
Ho Chi Minh City 34
Ogden 31
London 29
Santa Clara 28
Mexico City 26
San Mateo 25
São Paulo 24
Frankfurt am Main 23
Helsinki 20
Hanoi 18
Brussels 16
Tokyo 16
Kunming 14
Warsaw 14
Brooklyn 13
Toronto 13
Hefei 12
Johannesburg 12
Nuremberg 12
Redwood City 12
Chennai 11
Denver 11
Norwalk 11
Phoenix 11
Washington 11
Boston 10
Buffalo 10
Genoa 10
Nanjing 10
Turku 10
Atlanta 9
Belo Horizonte 9
Falkenstein 9
Montreal 9
Rio de Janeiro 9
San Francisco 9
Stockholm 9
Orem 8
Varese 8
Vienna 8
Cavaria con Premezzo 7
Verona 7
Ankara 6
Berlin 6
Bologna 6
Nanchang 6
Pune 6
Amsterdam 5
Caxias do Sul 5
Chiswick 5
Cincinnati 5
Falls Church 5
Guangzhou 5
Guayaquil 5
Jinan 5
Manchester 5
New Delhi 5
Turin 5
Antibes 4
Bexley 4
Bollate 4
Brasília 4
Des Moines 4
Dhaka 4
Haiphong 4
Istanbul 4
Legnano 4
Missaglia 4
Totale 8.144
Nome #
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 318
Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL) 249
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 230
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells 221
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis 219
Right ventricular remodelling in mild hypertensive patients: role of left ventricular morpho-functional parameters 203
Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis 199
A particular case of AML patient with the polymorphism G105G (rs11554137) and the missense mutation R132C in IDH1 gene 187
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—comment 183
sRAGE and early signs of cardiac target organ damage in mild hypertensives 183
Acute myeloid leukemia with associated translocation t(15;17) and 11q23/MLL abnormality 182
Fatal Splenic Rupture in a Previously Undiagnosed Multiple Myeloma: Morphological, Immunophenotypical and Molecular Cytogenetic Analyses 180
JAK2, 46/1 haplotype and chronic myelogenous leukemia: diagnostic and therapeutic potential 180
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 175
In vitro effects of Apixaban on 5 different cancer cell lines 175
Clinical Impact of an Accurate Genetic Characterization of Older Acute Myeloid Leukemia Patients: A Report from the Northern Italy Leukemia Group (NILG) Randomized Trial 02/06 175
Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis 174
Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases 174
JAK2-V617F mutation and Philadelphia positive chronic myeloid leukemia. 173
Assessing residual disease in imatinib-treated CML patients by DNA compared to MRNA assays 169
JAK2 mutation and atypical chronic myeloid leukemia 168
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. 168
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 166
Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR) 165
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML 165
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 163
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 162
Tirosine kinase inhibitors adverse events 160
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 159
Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia 159
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia 155
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study). 154
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia 143
Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia 139
Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-centre experience 138
Metabolic tumour volume and response to therapy in diffuse large B cell lymphoma 135
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people 133
Caspofungin Primary Antifungal Prophylaxis in Acute Leukemia Patients During Induction Therapy: Results of a Prospective Phase II Multicentric Study (ProfilC Study) 132
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 132
Prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis 128
Negative impact of high body mass index on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells 127
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 125
What changed in the Italian internal medicine and geriatric wards during the lockdown 125
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study 124
Molecular monitoring of residual disease in chronic myeloid leukemia by genomic DNA compared with conventional mRNA analysis. 124
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 120
Clinical features, treatment and outcome of patients with low-grade gastric MALT lymphoma: a single centre experience 118
Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study 115
Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06 113
IN ADULT ACUTE MYELOID LEUKAEMIA (AML) ALL RISK SUBSETS BENEFIT FROM A SEQUENTIAL HIGH-DOSE PROGRAMME AS EARLY RESCUE OF FIRST INDUCTION FAILURE: A REPORT FROM NORTHERN ITALY LEUKAEMIA GROUP (NILG) 113
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 109
Tyrosin-Kinase Inhibitors Discontinuation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis 108
Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study 108
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 107
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 106
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG) 106
Composite follicular lymphoma and “early” (in situ and mantle zone growth pattern) mantle cell neoplasia: A rare entity with peculiar cytogenetic and clinical features 106
Pain and Frailty in Hospitalized Older Adults 105
CEOP 1-8 regimen for treatment of intermediate-high grade non-Hodgkin's lymphoma in elderly patients 104
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06 104
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry 103
Primary testicular non-Hodgkin lymphomas. A clinicopathologic study of nine cases 102
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 102
Antibiotic use and associated factors in a large sample of hospitalised older people 100
Primary non-Hodgkin's lymphoma of the kidney: A case report 99
NEXT GENERATION SEQUENCING (NGS) CONFIRMED THE ADVERSE CLINICAL IMPACT OF RUNX1 MUTATIONS IN A SUBSET OF ACUTE MYELOID LEUKEMIA NORMAL KARYOTYPE PATIENTS NEGATIVE FOR RISK DEFINING GENES MUTATIONS AND HOMOGENOUSLY TREATED WITHIN A CLINICAL TRIAL (NILG AML 02/06) 96
MOLECULAR PROLIFE BY NEXT GENERATION SEQUENCING OF ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE: CLINICAL RESULTS FROM THE PROSPECTIVE TRIAL 02/06 OF THE NORTHERN ITALY LEUKEMIA GROUP (NILG) 95
Subacute demyelinating polyneuropathy associated with B-cell lymphoma and IgM antibodies against myelin-associated glycoprotein responsive to rituximab 94
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 93
TWO-STEP RESPONSE-ORIENTED INDUCTION PREDICTS LONG-TERM OUTCOME OF ADULT PATIENTS WITH STANDARD- AND HIGH-RISK ACUTE MYELOID LEUKAEMIA (AML): A NORTHERN ITALY LEUKAEMIA GROUP (NILG) STUDY 92
Evaluation of international prognostic factors project for patients with advanced Hodgkin's disease: A single centre experience 90
CLINICAL SIGNIFICANCE OF END OF INDUCTION MINIMAL RESIDUAL DISEASE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION AFTER A SINGLE CHEMOTHERAPY COURSE 89
Primary gastric lymphomas. Clinico-pathological study and evaluation of prognostic factors in 65 cases treated surgically 82
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 81
Association of ARA-C, mitoxantrone and etoposide in elderly affected by acute myeloid leucemia 80
PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS-MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE 79
Post-Treatment Residual Disease Detection by Droplet Digital PCR in Hairy Cell Leukemia: Comparison with Allele Specific PCR and Immunohistochemistry 72
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients 71
Association of hairy cell leucemia (HCL) with low-grade non Hodgkin lymphoma (NHL) successfully treated with retuximab. A case report 68
Low efficacy of thalidomide in improving response after induction in myeloma patients candidate to high-dose therapy 66
Integrated genomic, functional, and prognostic characterization of atypical chronic myeloid leukemia 55
Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 52
High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy 52
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 50
BCL2 in follicular lymphomas (FL): the overrated guy? 50
Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer 49
Multicentric castleman disease with splenic presentation: report of two rare cases with focus on histopathological features and review of the literature 48
A case of multicentric Castleman's disease mimicking non-Hodgkin lymphoma: when splenectomy is diagnostic and therapeutic 46
Correction to: Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta‑analysis (Internal and Emergency Medicine, (2023), 18, 2, (535-547), 10.1007/s11739-023-03208-9) 44
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 38
Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta-analysis 32
Totale 11.510
Categoria #
all - tutte 51.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.329 0 0 0 0 0 213 148 152 212 233 167 204
2021/2022915 134 98 40 55 35 106 33 30 53 171 64 96
2022/20231.253 130 86 90 128 101 234 1 189 186 37 36 35
2023/20241.724 263 260 244 319 303 159 16 27 62 30 17 24
2024/20251.369 25 25 252 40 55 75 63 95 148 122 122 347
2025/20261.701 294 250 236 504 337 80 0 0 0 0 0 0
Totale 11.510